You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Table TDI-10 part (vi). New clients entering outpatient treatment: age and primary drug at treatment in 2003 for those countries supplying data. Number of clients using hallucinogens as primary drug

Country

<15

15-19

20-24

25-29

30-34

35-39

40-44

45+

Age known

Age not known

Total

Czech Republic

0

4

2

0

0

0

0

0

6

0

6

Germany

0

26

21

8

0

0

0

1

56

0

56

Greece

0

0

0

1

0

0

0

0

1

0

1

Latvia

0

1

0

0

0

0

0

0

1

0

1

Hungary

0

1

8

2

1

0

0

0

12

0

12

Netherlands

0

3

1

1

6

6

6

30

53

0

53

Slovakia

0

2

1

0

0

0

0

0

3

0

3

Finland

0

2

0

0

0

0

0

0

2

0

2

United Kingdom

0

6

7

6

4

1

0

0

24

0

24

Romania

0

1

0

0

1

0

0

0

2

0

2

Total

0

46

40

18

12

7

6

31

160

0

160

Source:

2004 Reitox national reports - TDI outpatient treatment centres – see [Table TDI-14]

Data filter | tditab10f-en.xml